Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Entheon Biomedical Corp (ENBI.CN)

Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,940
  • Shares Outstanding, K 13,859
  • Annual Sales, $ 0 K
  • Annual Income, $ -318 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.88

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1000 +40.00%
on 04/03/25
0.1750 -20.00%
on 03/21/25
-0.0100 (-6.67%)
since 03/14/25
3-Month
0.1000 +40.00%
on 04/03/25
0.4500 -68.89%
on 01/24/25
-0.1300 (-48.15%)
since 01/17/25
52-Week
0.0750 +86.67%
on 07/19/24
0.4500 -68.89%
on 01/24/25
-0.0100 (-6.67%)
since 04/17/24

Most Recent Stories

More News
Entheon Announces Change of Directors

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands...

ENBI.CN : 0.1400 (+27.27%)
ENTBF : 0.0631 (-20.33%)
Entheon Issues Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that the Company has granted options...

ENBI.CN : 0.1400 (+27.27%)
ENTBF : 0.0631 (-20.33%)
Entheon Announces Termination of Mentis AI Agreement

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that, further to its news release...

ENBI.CN : 0.1400 (+27.27%)
ENTBF : 0.0631 (-20.33%)
Entheon Announces Agreement to Acquire Mentis AI

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered...

ENBI.CN : 0.1400 (+27.27%)
ENTBF : 0.0631 (-20.33%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition...

ENBI.CN : 0.1400 (+27.27%)
CYBN.NE : 10.1000 (-1.37%)
CYBN : 7.35 (-1.34%)
ENTBF : 0.0631 (-20.33%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

ENBI.CN : 0.1400 (+27.27%)
CMPS : 3.13 (+4.68%)
CYBN.NE : 10.1000 (-1.37%)
ATAI : 1.4700 (+3.52%)
FTRP : 0.8421 (+1.07%)
CYBN : 7.35 (-1.34%)
FTRP.TO : 1.09 (+5.83%)
ENTBF : 0.0631 (-20.33%)
SILO : 1.0748 (+4.35%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited,...

ENBI.CN : 0.1400 (+27.27%)
CYBN.NE : 10.1000 (-1.37%)
CYBN : 7.35 (-1.34%)
ENTBF : 0.0631 (-20.33%)
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through...

ENBI.CN : 0.1400 (+27.27%)
CYBN.NE : 10.1000 (-1.37%)
CYBN : 7.35 (-1.34%)
ENTBF : 0.0631 (-20.33%)
Cybin Acquires DMT Clinical Study from Entheon Biomedical

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through its wholly-owned...

ENBI.CN : 0.1400 (+27.27%)
CYBN.NE : 10.1000 (-1.37%)
CYBN : 7.35 (-1.34%)
ENTBF : 0.0631 (-20.33%)
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research

AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in...

ENBI.CN : 0.1400 (+27.27%)
OTC.VN : 0.275 (-5.17%)
EHVVF : 0.0022 (unch)
ENTBF : 0.0631 (-20.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.

See More

Key Turning Points

3rd Resistance Point 0.1400
2nd Resistance Point 0.1400
1st Resistance Point 0.1400
Last Price 0.1400
1st Support Level 0.1400
2nd Support Level 0.1400
3rd Support Level 0.1400

See More

52-Week High 0.4500
Fibonacci 61.8% 0.3067
Fibonacci 50% 0.2625
Fibonacci 38.2% 0.2182
Last Price 0.1400
52-Week Low 0.0750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar